🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal

RecruitingNAAges 30 Years - anyAllKathmandu University School of Medical Sciences
NCT07432126 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Hypertension (HTN) and diabetes mellitus are significant global public health challenges, contributing to 13.5% of premature deaths, 54% of incident strokes, and 47% of coronary heart disease cases (HTN), and increasing risks of cardiovascular diseases, kidney failure, and other complications (diabetes). In Nepal, HTN prevalence is 24.5% and diabetes affects 5.8% of adults (2019 Nepal STEPS Survey), with many cases undiagnosed or poorly managed, and an estimated 60% co-morbidity among diabetic individuals. Nepal's Package of Essential Non-Communicable Diseases (PEN), implemented since 2017, targets both conditions, but multi-level barriers limit its facility-based effectiveness. This study addresses the need for cost-effective, evidence-based strategies for HTN and diabetes management in low-resource settings, focusing on marginalized populations. It proposes a Type II hybrid implementat

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 30 years or older * have a high blood pressure of 140/90 mmHg or under hypertension medication * have a high blood sugar of 6.5% or more (hba1c) or under diabetes medication are able to provide informed consent Exclusion Criteria: * any form of disabilities limiting participation in the study * severe illness requiring bed rest, and * pregnant women, due to their special health needs.
💊

What it tests

  • Integrated management of hypertension and diabetes using group care approach
📍

Where

1 site
Institute for Implementation Science and Health
Kavre, Nepal
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy